- Filed
- Mar 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 20, 2025 | 74.34M sh |
| Revenue | FY 2024 · Dec 31, 2024 | $0 |
| Revenue | FY 2024 · Dec 31, 2023 | $260.5K |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 6.03M sh |
| Capex | FY 2024 · Dec 31, 2023 | $14.24K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$18.09M |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2023 | $9.2M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $3.44M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $3.53M |
| Current Assets | FY 2024 · Dec 31, 2023 | $14.21M |
| Total Assets | FY 2024 · Dec 31, 2023 | $14.51M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$3.16 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$3.16 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $6.73M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $13.62M |
| Net Income | FY 2024 · Dec 31, 2023 | −$19.03M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$20.09M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $21.04M |